Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transcytosis of IgG01:15

Transcytosis of IgG

3.0K
Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
3.0K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

43
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
43
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

11.4K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.4K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

33
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
33
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

62
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
62
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

36
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
36

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[New aspects of systemic lupus erythematosus and systemic sclerosis].

Zeitschrift fur Rheumatologie·2024
Same author

Impact of Risk Factors on COVID-19 Outcomes in Unvaccinated People With Rheumatic Diseases: A Comparative Analysis of Pandemic Epochs Using the COVID-19 Global Rheumatology Alliance Registry.

Arthritis care & research·2023
Same author

Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases.

RMD open·2023
Same author

Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 Global Rheumatology Alliance.

Annals of the rheumatic diseases·2022
Same author

[When should methotrexate hepatopathy be suspected and which measures are advisable?]

Zeitschrift fur Rheumatologie·2021
Same author

TNFi is associated with positive outcome, but JAKi and rituximab are associated with negative outcome of SARS-CoV-2 infection in patients with RMD.

RMD open·2021

Related Experiment Video

Updated: Oct 1, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.6K

[Cryoglobulinemic vasculitis].

Christof Specker1, Denise Passens2, Jörg Schlaak3

  • 1Klinik für Rheumatologie & Klinische Immunologie, Evangelisches Krankenhaus, Kliniken Essen-Mitte, Pattbergstr. 1-3, 45239, Essen, Deutschland. c.specker@kem-med.com.

Zeitschrift Fur Rheumatologie
|March 8, 2022
PubMed
Summary

Cryoglobulinemic vasculitis is a rare small vessel disease diagnosed by detecting cryoglobulins (CG). Laboratory testing requires maintaining blood samples at 37°C to prevent protein precipitation.

Keywords:
CryoglobulinemiaCryoglobulinsHepatitis CImmunosuppressionVasculitis

More Related Videos

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.6K

Related Experiment Videos

Last Updated: Oct 1, 2025

Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.6K
An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

7.3K
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

24.6K

Area of Science:

  • Immunology
  • Rheumatology
  • Hematology

Background:

  • Cryoglobulinemic vasculitis (CV) is a rare immune complex disease affecting small blood vessels.
  • Characterized by the presence of cryoglobulins (CG), serum proteins precipitating at low temperatures.
  • Laboratory diagnosis is challenging due to the need for continuous sample temperature maintenance at 37°C.

Purpose of the Study:

  • To provide a comprehensive overview of cryoglobulinemic vasculitis.
  • To discuss the classification, causes, diagnostic challenges, and treatment strategies for CV.
  • To highlight the importance of identifying and treating underlying conditions.

Main Methods:

  • Review of existing literature on cryoglobulinemic vasculitis.
  • Analysis of cryoglobulin classification (Types I-III) and associated conditions.
  • Discussion of diagnostic laboratory requirements and therapeutic approaches.

Main Results:

  • Cryoglobulins are classified into three types (I-III), each linked to specific diseases.
  • Common causes include hematological, virological (most commonly Hepatitis C), and autoimmune diseases.
  • Effective treatment necessitates addressing the underlying disease, with antiviral therapy for Hepatitis C offering a potential cure.

Conclusions:

  • Cryoglobulinemic vasculitis requires careful laboratory handling to ensure accurate diagnosis.
  • Treatment focuses on managing the underlying cause and immunosuppression to prevent organ damage.
  • Early diagnosis and management of associated conditions are crucial for patient outcomes.